Occipital bone and tumor-induced osteomalacia: a rare tumor site for an uncommon paraneoplastic syndrome

[1]  A. Corsi,et al.  "Non-phosphaturic" Variant of Phosphaturic Mesenchymal Tumor of the Middle Ear Expressing Multiple Phosphatonins. , 2023, Ear, nose, & throat journal.

[2]  P. Houillier,et al.  Global guidance for the recognition, diagnosis, and management of tumor‐induced osteomalacia , 2022, Journal of internal medicine.

[3]  A. Corsi,et al.  Appropriate dosing of burosumab in tumor-induced osteomalacia , 2022, Osteoporosis International.

[4]  R. Thakker,et al.  TUMOR-INDUCED OSTEOMALACIA: A COMPREHENSIVE REVIEW. , 2022, Endocrine reviews.

[5]  R. Kumar,et al.  Phosphatonins: From Discovery to Therapeutics. , 2022, Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists.

[6]  V. Lele,et al.  A Pictorial Essay of Somatostatin Receptor Imaging in Tumor-Induced Osteomalacia: A Single Institutional Experience , 2022, Indian journal of nuclear medicine : IJNM : the official journal of the Society of Nuclear Medicine, India.

[7]  R. Kumar,et al.  Burosumab for the Treatment of Tumor‐Induced Osteomalacia , 2020, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[8]  Yutaka Takahashi,et al.  Interim Analysis of a Phase 2 Open‐Label Trial Assessing Burosumab Efficacy and Safety in Patients With Tumor‐Induced Osteomalacia , 2020, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[9]  A. Corsi,et al.  Naso-Ethmoidal Phosphaturic Mesenchymal Tumor: A Rare Tumor Site for an Uncommon Paraneoplastic Syndrome , 2020, Ear, nose, & throat journal.

[10]  W. Lv,et al.  Nonremission and Recurrent Tumor‐Induced Osteomalacia: A Retrospective Study , 2019, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[11]  I. Gumussoy,et al.  Morphometric analysis of occipital condyles using alternative imaging technique , 2019, Surgical and Radiologic Anatomy.

[12]  A. Mahajan,et al.  Tumor induced osteomalacia in head and neck region: single center experience and systematic review , 2019, Endocrine connections.

[13]  F. Remotti,et al.  Tumor-induced osteomalacia - Current imaging modalities and a systematic approach for tumor localization. , 2019, Clinical imaging.

[14]  N. Saito,et al.  Definitive surgical treatment of osteomalacia induced by skull base tumor and determination of the half-life of serum fibroblast growth factor 23. , 2017, Endocrine journal.

[15]  M. Panigrahi,et al.  Unusual calvarial tumour-oncogenic osteomalacia , 2017, British journal of neurosurgery.

[16]  R. Tubbs,et al.  Update on the Notochord Including its Embryology, Molecular Development, and Pathology: A Primer for the Clinician , 2017, Cureus.

[17]  V. Billa,et al.  Tumor-induced hypophosphatemia , 2017, Indian journal of nephrology.

[18]  S. Basu,et al.  177Lu-DOTATATE PRRT in Recurrent Skull-Base Phosphaturic Mesenchymal Tumor Causing Osteomalacia: A Potential Application of PRRT Beyond Neuroendocrine Tumors , 2016, The Journal of Nuclear Medicine Technology.

[19]  K. Patel,et al.  Phosphaturic Mesenchymal Tumors Involving Skull Bones: Report of Two Rare Cases , 2019, Asian journal of neurosurgery.

[20]  Y. Iwai,et al.  Phosphaturic mesenchymal tumor with symptoms related to osteomalacia that appeared one year after tumorectomy. , 2006, Internal medicine.